Deltacarbon

Charcoal, Activated

Treatment option:

Medically reviewed

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Deltacarbon

Quick Facts About Deltacarbon

Property	Description
Active ingredient	Charcoal, Activated (Carbo activatus)
Form	Tablets, capsules, powder for oral suspension
Pharmacological class	Intestinal adsorbent, Non-specific antidote
Common use	General reduction of toxin and gas absorption
Origin	Natural (derived from carbonaceous materials)

What is Deltacarbon and How is it Classified?

Deltacarbon is a single-ingredient medicinal preparation whose active component is Charcoal, Activated. It is classified pharmacologically as an Intestinal adsorbent and a general detoxifying agent. This classification highlights that the drug is non-systemic, meaning its principal action is localized entirely within the gastrointestinal tract and is not absorbed into the body’s bloodstream.

Activated charcoal is a non-specific agent used in the emergency treatment of certain kinds of poisoning because of its ability to bind to toxins. This verifies its fundamental function: the medicine works to physically trap numerous harmful substances before they can be systemically absorbed.

Composition, Origin, and Available Forms

The Activated charcoal in Deltacarbon is an amorphous form of carbon that originates from natural sources, typically derived from materials like wood or coconut shells. These materials undergo specific activation processes to create a high-affinity, porous structure with an immense internal surface area. The preparation is designed for oral administration and is available in forms such as tablets and capsules, which offer portable, fixed-dose options, or as a powder for oral suspension, a form often necessary when a large, rapid-acting dose is required.

General Purpose of this Adsorbent

The fundamental purpose of Deltacarbon is to prevent the absorption of a broad range of ingested substances, including organic toxins, chemicals, and excess intestinal gases. This effect is achieved through adsorption, a physical process where molecules adhere to the surface of the charcoal and become sequestered. By trapping these unwanted agents in the gut, the preparation supports their elimination and helps to reduce the overall systemic burden of these compounds.

Regulatory References

What side effects are possible with Deltacarbon?

Possible side effects and safety information for Deltacarbon

Deltacarbon (Activated Charcoal) is associated with adverse reactions primarily related to the gastrointestinal and respiratory systems. Safety information is based on official governmental regulatory documents.

Adverse Reaction Scope

Common Adverse Reactions:

Constipation
Black stools (expected due to the nature of the product)
Nausea and Vomiting (particularly with rapid administration)

Serious and Clinically Significant Adverse Reactions: Serious adverse events involve obstruction and pulmonary risk, and include:

Aspiration Pneumonitis or Airway Obstruction: This is the most significant risk, potentially leading to fatality, and occurs when the product is accidentally inhaled into the lungs (aspiration).
Gastrointestinal Obstruction or Bowel Blockage (Ileus): This risk increases with multiple-dose regimens or in individuals with pre-existing conditions that slow intestinal motility, such as those with certain GI disorders or those taking drugs like opioids.
Severe Allergic Reactions: Hives, difficulty breathing, or swelling of the face, lips, tongue, or throat are rare but serious events.

Safety-Related Restrictions and Considerations

Contraindications: Deltacarbon is contraindicated in patients with an unprotected airway (depressed level of consciousness) without intubation due to the high aspiration risk. It must also not be used in the presence of an intestinal obstruction or conditions that significantly slow the digestive tract, or when there is a high threat of GI perforation or hemorrhage.

Drug Interactions: The product binds to and may reduce the absorption and efficacy of orally administered medications, including prescription drugs (e.g., contraceptives, certain heart or seizure medicines) and other substances like alcohol. A time separation between the administration of Deltacarbon and other oral drugs is generally required to mitigate this interaction.

Safety Monitoring Notes: Airway protection status must be assessed prior to administration. Monitoring for emesis and signs of intestinal blockage is necessary during use.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documents classify Deltacarbon (Activated Charcoal) overdose based on mechanical complications, as the active substance is non-systemic and not absorbed into the bloodstream. Overdose presentations are localized to the gastrointestinal (GI) tract and the respiratory system, requiring specific emergency actions.

Documented Manifestations and Severe Outcomes

Overdose often presents with severe gastrointestinal complications. Documented manifestations include constipation, diarrhea, and emesis (vomiting), with stools appearing darkened. The primary life-threatening risks associated with excessive administration are pulmonary aspiration leading to Aspiration Pneumonitis, and Gastrointestinal Obstruction caused by charcoal bezoar formation.

When to Seek Immediate Medical Help

Regulatory statements require that users seek immediate medical attention upon the onset of life-threatening symptoms, such as signs of aspiration or acute bowel obstruction. The official emergency action mandated is to discontinue medication immediately. Furthermore, an adequate airway assessment is required to mitigate aspiration risk. Patients with pre-existing motility disorders or those taking medications like opioids are noted to be at increased risk of GI complications. Treatment is solely symptomatic and supportive, as no specific antidote is known.

Therapeutic Uses of Deltacarbon

What Deltacarbon Treats: Main Uses and Benefits

Deltacarbon is commonly used to provide supportive relief across clinical settings marked by increased discomfort or systemic burden. The primary application is in acute clinical situations involving the oral ingestion of certain substances with the potential for serious toxicity or drug overdose. Its use is associated with reducing the systemic burden of the ingested toxin, which may assist with maintaining functional stability during difficult episodes.

The medication is relevant for a broad range of symptoms related to physical discomfort, including excessive flatulence, abdominal bloating, and associated pressure. It also provides supportive therapeutic benefit in specific chronic contexts, such as for patients with impaired kidney function. Its use is applied across domains where additional symptomatic support is needed to address symptoms related to heightened physiological stress.

Summary of Therapeutic Focus

Symptom Focus	Primary Benefit	Clinical Context
Bloating & Flatulence	Easing abdominal pressure	Episodic or recurrent discomfort
Systemic Toxin Burden	Assisting with symptom burden	Acute ingestion scenarios
Physiological Stress	Supportive symptom management	Chronic kidney impairment

Regulatory References

NIH StatPearls overview

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

Deltacarbon (activated charcoal) eligibility is defined by absolute prohibitions and specific restrictions based on the patient's physiological state and the nature of the condition being treated, as documented in governmental and authoritative clinical guidance.

Absolute Contraindications

The medicine must not be used if any of the following conditions are present, due to the severe risk of complications:

Unprotected Airway: Patients with a depressed level of consciousness or absent gag reflex who are not intubated. This is a major risk factor for potentially fatal pulmonary aspiration.
Gastrointestinal Obstruction: Known or suspected intestinal obstruction (ileus) or severely decreased gastrointestinal motility.
Caustic or Hydrocarbon Ingestion: After the swallowing of strong acids, alkalis, or petroleum distillates, as the charcoal is ineffective and may complicate management.

Population and Formulation Restrictions

Population / Condition	Regulatory Status	Restriction Basis
Infants (Under 1 year)	Not Recommended	Safety not established; high risk of severe dehydration with cathartic formulations.
Hereditary Fructose Intolerance	Contraindicated	Applies to formulations containing sorbitol.
Older Adults	Caution/Restricted Use	Increased risk of dehydration and electrolyte imbalances with cathartic-containing formulations.
Pregnancy/Lactation	Generally Allowed	Not absorbed systemically; therefore, not expected to result in significant fetal or infant exposure.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Deltacarbon (based on activated charcoal) primarily interacts with other substances via pharmacokinetic reduction of absorption due to its high adsorptive capacity in the gastrointestinal tract. This binding reduces the amount of co-administered medicine available for systemic absorption, potentially leading to treatment failure or loss of efficacy for the interacting drug.

Interacting Substances and Constraints

The most significant interaction is the general reduction in the absorption of all orally administered medicinal products.

Substance Category	Interaction Mechanism & Consequence
Oral Drugs (General)	Reduced absorption; potential loss of efficacy due to lower plasma levels.
Specific Narrow Therapeutic Index Drugs	Reduced absorption, requiring close monitoring for drugs like digoxin and phenytoin.
Oral Contraceptives	Reduced absorption, potentially compromising efficacy.
Specific Antidotes	Binding (e.g., to ipecac syrup or acetylcysteine) reducing the antidote's intended effect.

Administration Requirements

Official regulatory information requires time separation to minimize the risk of adsorption. Deltacarbon should be taken at least one hour after most other orally administered medications. Specific regulatory advice dictates taking it at least 3 hours after or 12 hours before oral contraceptive pills to prevent compromise of contraceptive effectiveness. Caution is noted for patients with compromised gastrointestinal peristalsis.

Mechanism of Action

Deltacarbon's primary mechanism is physical adsorption (physisorption), not a biological receptor interaction. Its porous structure acts as a massive internal surface area to non-covalently sequester toxins, drugs, and intestinal gases entirely within the gastrointestinal lumen via weak non-covalent forces. This process is immediate and strictly localized, which decreases the concentration of substance available for absorption across the intestinal lining. By lowering the free concentration of substances in the gut, the charcoal creates a concentration sink. This sink establishes a powerful gradient that promotes the back-diffusion of circulating toxins from the bloodstream back into the lumen. This mechanistic cascade accelerates the clearance rate of the bound substance from the gastrointestinal tract by interrupting the natural recycling of toxins (enterohepatic recirculation) and forces their expulsion via the feces. The drug is a non-specific adsorbent; its effectiveness is strongest for non-polar, large organic molecules, while highly ionized or polar substances, such as metal ions, exhibit significantly weaker binding affinity. This constraint determines the physicochemical limits of the binding mechanism.

Dosage and Administration Information

How to Use Deltacarbon: Official Administration Guidelines

Following the labeled instructions for any medicine is essential for proper administration and to ensure the dose regimen is maintained. The official guidelines for Deltacarbon define the specific procedure for its use.

Administration Procedure

Administration Scope	Official Instruction
Route of Administration	Oral
Dosing Schedule	Take one 10 mg tablet once daily.
Timing in Relation to Meals	May be taken with or without food.
Preparation Requirements	Swallow the tablet whole. Do not crush, chew, or split the tablet.
Age-Group Rules	Approved for use in adults 18 years of age and older.
Missed-Dose Rules	If a dose is missed, take it as soon as remembered unless it is near the time for the next scheduled dose. Do not take two doses to make up for a missed dose.
Special Procedural Conditions	None stated other than the required swallowing method.

Official Step Sequence

The authorized administration protocol involves three key procedural steps to correctly use the medicine as intended:

Take out a single Deltacarbon 10 mg tablet.
Swallow the tablet intact with liquid.
Administer the dose once every 24 hours, maintaining a consistent daily schedule.

Connection to the Overall Use Protocol

This structured approach ensures that the medicine is consistently taken by the oral route at the designated 10 mg daily dose. The instructions define the correct preparation, such as swallowing the tablet whole, and clarify the actions to be taken in case of a missed dose, thereby providing a standardized regimen for patient adherence.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Deltacarbon

Evidence for Use in Acute Ingestions and Poisoning

Research examined the use of activated charcoal in urgent settings, relevant in trials assessing short-term or episodic symptom patterns following episodes where symptoms become more noticeable due to the acute oral ingestion of certain substances. Studies involving healthy volunteers consistently reported measurements where data show patterns related to altered systemic availability of the co-administered substance when administered immediately. However, when research was evaluated in actual overdose patients, findings were mixed regarding outcomes reflecting daily functioning or activity level, such as survival rates or time spent in the hospital. Long-term effects are not fully established, and certainty remains low for some severe cases, as much of the data comes from studies with follow-up durations that were limited.

Evidence for Relief of Gas and Abdominal Bloating

Research explored the potential role of activated charcoal in managing outcomes related to physical discomfort, specifically patient-reported outcomes describing perceived discomfort related to excessive intestinal gas and bloating. Studies explored this area using small-scale, short-term trials. Findings describe patterns observed in the studies where some trials reported measurements of changes in breath hydrogen levels, which was associated with some patient-reported experiences of changes in reported flatulence or abdominal discomfort. However, findings were mixed and evidence is limited, as the results vary across studies regarding the patterns observed with specific types of gas produced in the gut. Sample sizes were modest, contributing to the finding that certainty remains low in this area.

What is Still Uncertain About Deltacarbon Evidence

This section brings together the areas where the research landscape remains incomplete and certainty is lowest. Evidence is limited in demonstrating definitive changes in patient-centered outcomes (like survival or long-term functional status) across several indications. Long-term effects are not fully established because follow-up durations were limited in most trials. Findings were mixed regarding the consistency of patterns observed in conditions characterized by fluctuating or episodic manifestations. Furthermore, data for certain groups remain insufficient, including pregnant individuals and specific subgroups within the Chronic Kidney Disease population. The research provides context but not individual predictions.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Deltacarbon (FAQ)

Q: Can I drink alcohol while taking Deltacarbon?

Official health guidance indicates that consumption of alcohol is not explicitly restricted while taking Deltacarbon. As with any medication, consultation with a healthcare professional is recommended for specific concerns, especially those related to pre-existing conditions or liver health.

Q: What are the common side effects of Deltacarbon?

According to official product information, some of the most frequently reported adverse reactions include nausea, vomiting, diarrhea, and pain in the abdomen. Other common effects mentioned in regulatory documents are headache and dizziness. This information is available in the official prescribing documentation.

Q: Can I take Deltacarbon during pregnancy?

Regulatory documents state that use is generally advised against during pregnancy unless the prescriber concludes that the potential benefit justifies the potential risk. In some instances, the drug may be continued to manage chronic autoimmune diseases. Specific guidance on its use during pregnancy must be provided by a healthcare professional.

Q: Does this medication cause sleepiness or affect mental focus?

Official labeling mentions that reported adverse effects include dizziness and neuropsychiatric reactions, which are changes related to the nervous system and mental state. While drowsiness is generally not listed as a common effect, it has been noted in instances of overdose. Individuals should be aware of these potential effects when driving or operating machinery.

Q: Is it safe for children under the age of 5 to use?

Regulatory information indicates that the safety and effectiveness of chronic use of this drug in young children for conditions like juvenile idiopathic arthritis have not been definitively established. Children are highly sensitive to this class of compounds, and accidental ingestion of even a small amount has been reported to be fatal. Due to this risk, measures to prevent accidental ingestion are critical.

How should Deltacarbon be stored and disposed of?

How to Store and Dispose of Deltacarbon

Deltacarbon must be stored according to regulatory requirements to preserve its quality and stability. The medicine is required to be kept in a cool, dry place where the temperature is maintained below 30 C. To maintain product integrity and prevent degradation, the container must be kept tightly closed and protected from light and moisture. As a standard safety measure for all medications, the product must always be stored out of the sight and reach of children.

Disposal Requirements

Expired or unused Deltacarbon must not be flushed down the toilet or poured into a drain. The official regulatory guidance recommends utilizing a drug take-back program. If a program is unavailable, the medicine should be mixed with an undesirable substance, such as used coffee grounds, and placed in a sealed bag before being disposed of in the household trash, in accordance with authorized instructions.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Thailand

A-Z Index:

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z